Solid tumors
CNS germinoma (brain germinoma)
Also called Central nervous system germinoma
If you or someone you love has just heard this diagnosis, start here. This guide explains what the condition is, how it is usually treated and where a transplant fits.
A CNS germinoma is a rare tumor of the brain that starts from germ cells. It is found most often in children, teens and young adults, usually near the pineal gland or just above the pituitary gland. Germinoma usually responds very well to treatment. Radiation, often after chemotherapy, cures most people. A stem cell transplant is not part of usual treatment. It is used only for some germinomas that come back, and then it returns the patient’s own stored cells, so no donor is needed.
Other names and abbreviations
CNS germinoma, intracranial germinoma, pineal germinoma, brain germ cell tumor, Intracranial germinoma, suprasellar germinoma
In short
- A CNS germinoma is a germ cell tumor in the brain. It is often near the pineal gland or above the pituitary, and it can affect vision, hormones or the flow of brain fluid.
- It is usually treated with radiation, often with chemotherapy to help tailor the radiation dose. Hormone replacement or other support is added when needed.
- For some tumors that come back, high-dose chemotherapy may be followed by a return of the patient's own stem cells. This step does not need a donor.
Jump to a section
Underlined words open a short explanation. See all terms
Where transplant fits
Autologous stem cell rescueComing from the patient's own body. In an autologous transplant, the patient's own stem cells are collected and stored, then given back after high-dose treatment. It does not use a donor. may be used with high-dose chemotherapyVery strong drug treatment given in large doses, often to kill cancer cells. It also destroys the bone marrow and can cause other serious side effects. A stem cell transplant usually follows to rebuild the marrow. for selected recurrent disease. It returns the patient’s own cells and is not routine first-line donor transplantationComing from another person. In an allogeneic, or donor, transplant, the stem cells come from a relative or an unrelated volunteer whose cells are a close enough match to the patient's..
Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health.
Key facts
- Who it affects
- CNS germinomas mainly affect children, adolescents and young adults.
- How common
- About 1 in every 750,000 people each year (0.134 per 100,000)Germinoma of the brain or spinal cord, all ages, Korea national cancer registry, 2005–2012 (age-standardized rate 0.134 per 100,000 a year); the study authors say CNS germ cell tumor rates in Korea are similar to those of Asian and Pacific Islander people in the United States, which are higher than U.S. rates overall; published 2017 Source: How common
- Cells used in a transplant
- The patient’s own collected blood-forming cells for autologous stem cell rescue, when that procedure is appropriate.
- Where a donor fits
- Usually the person’s own cells
The condition
What it is
A germinoma is a kind of germ cell tumor. Germ cells are cells in an unborn baby that later become sperm or eggs. Most germ cell tumors grow in the testicles or ovaries. When one forms in the brain or spinal cord, doctors call it a central nervous system (CNS) germ cell tumor.
CNS germ cell tumors are split into two main groups: germinomas and nongerminomatous germ cell tumors (NGGCTs). Germinoma is the most common type and has the best outlook. The two groups are treated very differently, so one of the care team’s first jobs is to tell them apart. A tumor that mixes germinoma with other germ cell types is grouped with the nongerminomatous tumors.
CNS germ cell tumors most often start near the pineal gland, a small gland deep in the middle of the brain (about 45 in 100). The next most common place is the suprasellar region, just above the pituitary gland (about 30 in 100). The pituitary controls many of the body’s hormones. About 5 to 10 in 100 people have tumors in both places at once, which is called bifocal. CNS germ cell tumors are found most often between ages 10 and 19 and more often in boys and men. In Western countries they make up 3 to 4 in every 100 brain tumors in children. In Japan and other Asian countries the share is higher, about 15 in 100.
About these numbers. Each one says which group of people it comes from, and the place and years where the source gives them. It describes what happened across that group, not what will happen to any one person. And a figure measured among people who had a transplant is not the same as the number of people who need one.
- About 3 in 4 (76%)CNS germ cell tumors that are germinomas
654 people of all ages diagnosed with a malignant germ cell tumor of the brain or spinal cord in Korea, 2005–2012 (national cancer registry); published 2017
Read the source: CNS germ cell tumors that are germinomas
What causes it
The cause of most CNS germ cell tumors is not known. One idea is that, while a baby grows in the womb, some early germ cells travel to the wrong place and later turn into a tumor. A study of chemical tags on the tumors’ DNA (methylation) supports this idea. Another idea is that the tumor starts from an early embryo cell that escaped the normal signals that control growth.
Lab studies have found changes in the tumor cells, for example in a gene called KIT and in genes that pass growth signals inside the cell. Researchers are still working out what these changes mean.
Some patterns are known. Boys and men are affected more often. The gap is largest for tumors in the pineal region, which are found mostly in males. Rates also differ by background. In U.S. cancer registry data from 1992 to 2010, people aged 10 to 29 of Asian or Pacific Islander descent had two to three times the rate of white people. Germ cell tumors are the most common kind of brain tumor reported in people with Down syndrome. Case reports also link Klinefelter syndrome, in which a male has an extra X chromosome, with germ cell tumors outside the testicles, including some in the brain.
Symptoms and effects
Symptoms depend on where the tumor is. A tumor above the pituitary often affects hormones first. The most common early sign is diabetes insipidus, which 70 to 90 in 100 people with a tumor there have. This is not sugar diabetes. The body cannot hold on to water, so a person is very thirsty and passes large amounts of clear urine, sometimes with bed-wetting. People can make up for it by drinking a lot, sometimes for months or years before the tumor is found. Later there may be slow growth, early or late puberty, and loss of vision as the tumor presses on the nerves to the eyes.
A tumor in the pineal region can block the flow of the fluid around the brain (cerebrospinal fluid). The fluid builds up, a problem called hydrocephalus, and raises the pressure inside the head. This causes headaches, nausea, vomiting and tiredness. Pineal tumors can also cause trouble looking up, double vision and changes in how the pupils react to light. These symptoms usually build over weeks to months.
Some signs are easy to miss, such as bed-wetting, loss of appetite, trouble with schoolwork or changes in mood or behavior. This can delay the diagnosis. Germinoma can spread through the fluid to other parts of the brain and spine, but it rarely spreads outside the brain and spinal cord.
Diagnosis and treatment
How CNS germinoma is diagnosed
Doctors start with a physical and neurological exam, an eye exam that checks side (peripheral) vision, and blood tests for pituitary hormones. An MRI of the brain and the whole spine, with contrast dye, shows where the tumor is and whether it has spread.
Scans alone cannot tell a germinoma from other germ cell tumors or other brain tumors. So doctors measure two tumor markers: alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (beta-hCG). They test the blood, and spinal fluid taken with a spinal tap (lumbar puncture) when that is safe. The fluid is also checked for tumor cells. A pure germinoma usually has a normal AFP. Some make a small amount of beta-hCG.
Because the markers are normal or only a little raised, a biopsy is usually needed to confirm a germinoma. It can be done through a small opening in the skull, sometimes with a thin camera (endoscope). In one North American trial, people with a very typical picture were treated as having germinoma without a biopsy. For example, some had tumors both in the pineal region and above the pituitary, or a pineal tumor with diabetes insipidus. They also had a normal AFP and only a slightly raised beta-hCG. The beta-hCG cut-off used to tell germinoma from other types is 50 IU/L in Europe and 100 IU/L in North America, and experts still question both.
Getting the type right matters, because germinoma and other germ cell tumors are treated very differently.
How it is treated
Germinomas are very sensitive to radiation and to chemotherapy. Radiation alone can cure them. For many years the standard was radiation to the whole brain and spine (craniospinal irradiation) with an extra dose to the tumor. Radiation to a growing brain can cause lasting problems, so care teams now aim to use less of it without losing the high cure rate.
In North America and Europe, a germinoma that has not spread is now often treated with chemotherapy first, for example carboplatin and etoposide. Radiation follows, and its dose depends on how well the tumor shrank. It covers the fluid-filled spaces of the brain (whole-ventricular irradiation), with a boost to the tumor. Radiation aimed only at the tumor led to more relapses in those fluid spaces, so it is not recommended. An international group tried chemotherapy alone, mainly in younger children. The tumor disappeared in most of them, but it came back or grew again in half. A germinoma that has already spread is usually treated with radiation to the whole brain and spine.
Surgery to remove a germinoma is not often used, but a biopsy may be needed to confirm the diagnosis. Some people need a tube (shunt) or another procedure to drain fluid from the brain. Hormone medicines replace the hormones the pituitary can no longer make. Some chemotherapy medicines need large amounts of fluid through a vein, which is harder to manage when a person has diabetes insipidus. Radiation is usually avoided in children under 3, and chemotherapy may be used instead to delay or reduce it.
If a germinoma comes back, it can often still be treated with a cure in mind. Options include more chemotherapy followed by more radiation. For people who already had radiation, high-dose chemotherapy followed by a return of their own stored stem cellsYoung cells that can grow into every type of blood cell: red cells that carry oxygen, white cells that fight infection and platelets that help blood clot. They are found in the bone marrow and the bloodstream. has also been used. Clinical trialsA research study that tests how well a new medical approach works in people. Trials can test new ways to screen for, prevent, diagnose or treat a disease. continue to test lower doses of radiation. One of them, the Children’s Oncology Group trial ACNS2321, was recruiting people aged 3 to 29 in 2026.
- 94.5%Alive with no return or growth of germinoma three years later
74 people aged 3 to 21 with germinoma that had not spread, whose tumor disappeared on chemotherapy and who then had lower-dose (18 Gy) whole-ventricular radiation, on the Children's Oncology Group ACNS1123 trial (North America); this estimate leaves out people who could not be assessed at 3 years, and the trial did not meet its preset goal when they were counted as failures; published 2022
Read the source: Alive with no return or growth of germinoma three years later
A stem cell transplant is not part of the usual first treatment for germinoma.
Kinds of treatment described for CNS germinoma (brain germinoma): supportive care, medicines, radiation, a transplant with the person’s own cells (for some people) and clinical trials.
After diagnosis, the options described here
Supportive care
Hormone medicines replace the hormones the pituitary can no longer make.
Medicines
A germinoma that has not spread is now often treated with chemotherapy first.
Radiation
Radiation covers the brain’s fluid-filled spaces, or the whole brain and spine if the tumor has spread, and surgery to remove the tumor is not often used.
Transplant with the person’s own cells, For some people
It is used only for some germinomas that come back, with high-dose chemotherapy and the person’s own stored stem cells.
What a transplant involvesClinical trials
Clinical trials continue to test lower doses of radiation.
These are the kinds of treatment this page describes, not a plan. Which ones fit, in what order and whether they are combined differs from person to person.
When transplant specialists are usually consulted
U.S. transplant guidelines from NMDP and ASTCT name germinoma. They say high-dose therapy with the patient’s own stem cells may be considered when a germinoma comes back, responds again to chemotherapy and does not leave a large tumor behind. They do not list a transplant as part of first treatment.
Read the guidanceWhat a transplant involves
- Step 1
: Collecting the person’s own cells
Medicines move stem cells out of the marrow and into the blood. The cells are then collected and frozen.
- Step 2
: High-dose treatment
The person receives strong treatment, usually high-dose chemotherapy.
- Step 3
: Cells returned, Day 0
The stored cells are thawed and given back through a vein, like a transfusion.
- Step 4
: Blood counts recover
The returned cells settle in the marrow and start making blood cells again.
- Step 5
: Follow-up
The care team keeps checking recovery and watches for infection and for the condition coming back.
Daily life and the donor’s role
Living with the condition
Treatment often means several rounds of chemotherapy and then a course of radiation. The scans and tests done at diagnosis are repeated to see how well treatment is working. Care is usually led by a pediatric oncologist or a radiation oncologist. The team may also include a neurosurgeon, an endocrinologist (hormone doctor), an eye doctor, a rehabilitation specialist, a psychologist, a social worker and a fertility specialist.
Hormone problems are common and often last. When the tumor has caused diabetes insipidus or other pituitary hormone losses, these usually stay even after the tumor is gone. Hormone replacement is then needed long term. Low pituitary function can affect growth, puberty, energy, thyroid function and fertility, so hormone levels are checked regularly.
Radiation to the brain can affect thinking, learning and memory. It can also affect vision, and in rare cases it leads to a stroke or a second tumor years later. These late effects can happen in teens and young adults as well as children. Follow-up with MRI scans continues for years, and many families also use school support and testing of thinking and learning skills (neuropsychology testing).
The donor’s role
No donor is involved in the usual treatment of a CNS germinoma. Most people are treated with chemotherapy and radiation and never need a stem cell transplantA treatment that gives a patient healthy blood-forming stem cells through a vein. The cells travel to the bone marrow and replace faulty marrow or marrow damaged by treatment. They can come from the patient or a donor..
A transplant is used only for some germinomas that come back. The care team then gives high-dose chemotherapy, which also destroys the blood-forming cells in the bone marrowThe soft, spongy tissue in the center of most bones. Red bone marrow holds the blood-forming stem cells that make red blood cells, white blood cells and platelets.. Before that treatment, stem cells are collected from the patient’s own blood or bone marrow and frozen. Afterward they are thawed and given back through a vein, where they rebuild the blood cells. This is called stem cell rescue, or an autologous transplant. It uses the patient’s own cells, so no registry match is needed.
U.S. transplant guidelines from NMDP and ASTCT say this own-cell treatment may be considered when a germinoma comes back and responds again to chemotherapy. A donor (allogeneic) transplant is not a standard treatment. European transplant experts (EBMT, 2025) say donor transplants for children with solid tumors should be explored only in clinical trials. Joining a registry helps people with many other conditions who do need a donor.
Highlighted here: the person’s own cells.
The person’s own cells
Autologous transplant, no donor
Collected from the person before treatment, then given back.
A relative
Donor transplant (allogeneic)
A brother or sister may be a full match. Parents and children can be half-matched donors.
An unrelated volunteer
Donor transplant (allogeneic)
Found through a donor registry.
Donated cord blood
Donor transplant (allogeneic)
Collected from a baby’s umbilical cord after birth and stored in a public bank.
Looking ahead
Looking ahead
Outlook for CNS germinoma
Germinoma has a very good outlook. The National Cancer Institute reports 5-year survival above 90% in studies of lower-dose radiation to the brain and spine. St. Jude reports survival of about 90% for children in the United States. Because survival is so high, research now focuses on using less radiation to reduce long-term effects while keeping cure rates high.
The outlook is also good for germinoma that has spread within the brain and spine when it is treated with radiation to the whole brain and spine. Many survivors live with lasting hormone problems or other effects of treatment, so long-term follow-up is part of care.
When germinoma comes back, it can often still be cured. A French study found that relapsedWhen a disease comes back after a period of getting better. Relapsed disease has returned after treatment helped for a time. germinoma was highly curable and that more radiation seemed to play a key role. It also stressed confirming the diagnosis with a biopsy at the start when tumor markers are normal.
About these numbers. They describe groups of people, not what will happen to any one person.
- 95%Alive five years after diagnosis
344 people of all ages diagnosed with germinoma of the brain or spinal cord in Korea, 2005–2010, followed to the end of 2013 (national cancer registry; observed survival from any cause); published 2017
Read the source: Alive five years after diagnosis - 98%Alive with no relapse five years later, when germinoma had spread at diagnosis
45 children and adults with germinoma that had spread within the brain and spine, treated with reduced-dose (24 Gy) radiation to the whole brain and spine, 17 of them after chemotherapy, on the European SIOP CNS GCT 96 trial (opened 1996); published 2013
Read the source: Alive with no relapse five years later, when germinoma had spread at diagnosis - 86%Alive five years after germinoma came back
14 people in France whose biopsy-proven germinoma came back after treatment on national protocols, relapses from 1990 to 2014; published 2020
Read the source: Alive five years after germinoma came back
These are results from groups of people treated in trials and registries. They describe groups, not a person, and cannot tell what will happen to any one child or adult.
Common questions
Is a brain germinoma cancer?
Yes. Germinoma is counted as a malignant (cancerous) tumor, and it is treated by cancer specialists. But it usually responds very well to treatment. Germinomas are very sensitive to radiation and chemotherapy, and the National Cancer Institute reports 5-year survival above 90% in studies of lower-dose radiation to the brain and spine. Germinoma is different from the other, harder-to-treat kinds of germ cell tumor in the brain, called nongerminomatous germ cell tumors.
What is the survival rate for germinoma?
Survival is high. The National Cancer Institute reports 5-year survival above 90% in studies of lower-dose radiation to the brain and spine, and St. Jude reports about 90% for children in the United States. In a Korean national registry study of people diagnosed from 2005 to 2010, 95% were alive five years later. The outlook section on this page gives these figures, with the groups they describe. They describe groups, not a person.
What are the first signs of a germinoma?
It depends on where the tumor is. A tumor near the pituitary often causes great thirst and passing large amounts of clear urine (diabetes insipidus), sometimes for months before the diagnosis. It can also cause slow growth, early or late puberty and vision problems. A tumor near the pineal gland can cause headaches, nausea and vomiting, trouble looking up and double vision. Bed-wetting, tiredness and trouble with schoolwork are also listed by the National Cancer Institute. These signs can have many other causes.
Will my child need a stem cell transplant or a donor?
Almost always, no. Germinoma is usually treated with chemotherapy and radiation. A stem cell transplant is used only for some germinomas that come back. Then high-dose chemotherapy is followed by a return of the patient’s own stem cells, which were collected and frozen beforehand. Because the cells are the patient’s own, no donor or registry match is needed. U.S. guidelines from NMDP and ASTCT say this may be considered when a germinoma comes back and responds again to chemotherapy.
Can germinoma come back after treatment?
Yes, though most people are cured. After radiation to the whole brain and spine, a germinoma that comes back usually does so where it started. After smaller radiation fields, it can come back in other parts of the brain, its fluid spaces or the spine. That is why MRI scans continue for years. When germinoma does come back, it can often still be cured with more chemotherapy and radiation, or sometimes with high-dose chemotherapy and the person’s own stem cells.
Can adults get a CNS germinoma?
Yes, but it is less common. St. Jude says about 9 in 10 CNS germ cell tumors are found in people younger than 20, most often in the early teen years. In a Korean national study of 2005 to 2012, about 1 in 13 CNS germ cell tumors was found in people aged 30 or older. Adults were included in the European SIOP CNS GCT 96 germinoma trial. The National Cancer Institute notes that treatment for adults may differ from treatment for children.
For your next appointment
CNS germinoma (brain germinoma)
From the Jada Bascom Foundation disease library, jadabascomfoundation.org. Printed .
Questions to bring to your care team
- Was the germinoma confirmed with a biopsy, and what were the AFP and beta-hCG levels in the blood and spinal fluid?
- Has the tumor spread within the brain or spine, and what radiation area and dose do you plan? Is a trial such as ACNS2321 open to us?
- Which hormone tests and replacements are needed, and who will manage diabetes insipidus during chemotherapy?
- Should we see a fertility specialist before treatment starts, and what school, memory and vision follow-up will there be?
- What is the exact name of the diagnosis or subtype, and what does it mean for treatment?
- What is the goal of each treatment you are suggesting?
- If a transplant is suggested, will it use the patient’s own cells? What happens before and after?
- How does a transplant compare with the other treatments on offer?
- Where can our family find support during treatment?
A one-page list to take to the next appointment, with room for notes.
Supporting someone with a diagnosisSupport for patients and families
These independent organizations offer information and support. JBF is not affiliated with them.
- American Brain Tumor Association Free CareLine, support groups, mentor programs and financial help for people with brain tumors and their caregivers.United States
- The Brain Tumour Charity Support and info line, online groups, counseling and information packs for children, adults and families affected by a brain tumor.United Kingdom
- Children's Brain Tumor Foundation Support groups, retreats, an educational advocacy program and bereavement support for children with brain and spinal cord tumors and their families.United States
Sources and further reading
- Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ)
NCI, Accessed 2026-09-05 - Indications for haematopoietic cell transplantation and CAR-T: 2025 EBMT practice recommendations
EBMT / Bone Marrow Transplantation, Accessed 2026-09-05 - Stem Cell and Bone Marrow Transplants for Cancer
NCI, Accessed 2026-09-05 - Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ), Patient Version
NCI, Updated 2024-11-06; accessed 2026-09-26 - 2024 Recommended Timing for Transplant Consultation
NMDP and American Society for Transplantation and Cellular Therapy (ASTCT), February 2024; accessed 2026-09-26 - Germ Cell Brain Tumors
St. Jude Children's Research Hospital (Together), Reviewed August 2025; accessed 2026-09-26 - Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012
Cancer Research and Treatment (Lee et al.), 2017-04 - Incidence patterns of central nervous system germ cell tumors: a SEER Study
Journal of Pediatric Hematology/Oncology (Goodwin et al.), 2009-08 - Incidence of intracranial germ cell tumors by race in the United States, 1992–2010
Journal of Neuro-Oncology (Poynter et al.), 2014-11 - Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome
Pediatric Blood & Cancer (Harris et al.), 2022-10 - Klinefelter syndrome and germ cell tumors: review of the literature
International Journal of Pediatric Endocrinology (Bonouvrie et al.), 2020-09-28 - Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study
Neuro-Oncology (Bartels et al., Children's Oncology Group), 2022-06 - A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma (ACNS2321, NCT06368817)
ClinicalTrials.gov, US National Library of Medicine, Recruiting; record updated 2026-08-25; accessed 2026-09-26 - SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma
Neuro-Oncology (Calaminus et al.), 2013-06 - Relapsing intracranial germ cell tumours warrant retreatment
European Journal of Cancer (Callec et al.), 2020-09
This information explains a condition and its treatments. It cannot diagnose an illness or recommend treatment for an individual. Your care team can explain how the evidence applies to you. Written and source-checked by the Jada Bascom Foundation. Each page lists the published sources it draws on.
Ways to help
Other patients need a donor.
A transplant for CNS germinoma (brain germinoma) usually uses the patient’s own cells, but thousands of other patients need a donor. For many of them, that donor is a stranger who joined a registry.
Join the registry
JBF points you to the official registry that serves your country. It explains who can join and what donation involves.
Support this work
Gifts to the Jada Bascom Foundation support donor-awareness education like this page, community outreach, drive planning and referrals to official registries.
Help a family find a donor
Our family guide explains practical ways to help someone who needs a donor. A registration drive can add many potential donors at once, for them and for others.
More in the library


